Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03196518 · ClinicalTrials.gov registry record · NA

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

A NA study of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03196518: Active NA study of Thyroid Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03196518 is a NA study of Thyroid Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 5 participants, below the 282-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03196518, a NA study of Thyroid Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and that does not interfere with the uptake of radioactive iodine used for therapy.

Conditions Studied

Interventions

  • PROCEDURE PET Imaging
  • OTHER 18F-tetrafluoroborate (18F-TFB)

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2017-06-16
Est. Completion 2026-06
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT03196518

The ClinicalTrials.gov registry entry for NCT03196518 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 282-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thyroid Cancer appearing as the primary indexed condition, and to 2 interventions - of which PET Imaging is the first listed.

NCT03196518 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03196518 about?

NCT03196518 is a clinical study titled "Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer". The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and that does not interfere with the uptake of radioactive iodine used for therapy.

What is the current status of trial NCT03196518?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2017-06-16. Estimated completion is 2026-06.

What conditions does trial NCT03196518 study?

This clinical trial studies the following conditions: Thyroid Cancer.

What interventions are being tested in trial NCT03196518?

The interventions under investigation include: PET Imaging (PROCEDURE), 18F-tetrafluoroborate (18F-TFB) (OTHER).

Who is sponsoring clinical trial NCT03196518?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03196518 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.